Acorda Announces FDA Acceptance of New Drug Application for Inbrija (levodopa inhalation powder)

7 years ago

by David Miller

969 Views

Written by David Miller

ARDSLEY, N.Y.–(BUSINESS WIRE) February 20, 2018 — Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its New Drug Application (NDA) for Inbrija. Inbrija is an…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!